Why in News?
World Blood Cancer Day (WBCD) is celebrated globally today, May 28, 2026. The primary emphasis of this year’s international campaign is a massive drive to register new bone marrow and blood stem cell donors to close the critical, life-threatening gap in matching matching-genetics tissue registries.
About
- Annual Observance: Marked globally every year on May 28.
- Origin: Founded in 2014 by DKMS, an international non-profit bone marrow donor registry based in Germany, to commemorate its creation and coordinate global anti-cancer movements.
- Official Symbol: The red ampersand (&) is the globally recognized symbol for the day, visually communicating that patients and donors are united in the fight against the disease.
- Core Mandate: To raise awareness, address standard treatment disparities, encourage genetic typing registration, and fund clinical hematology research.
Understanding Blood Cancer
- The Pathology: An umbrella medical term for malignant growths originating in the bone marrow, lymphatic system, or peripheral blood cells, which disrupt normal cell production and crush your body's immune system.
- Main Classifications: The disease primarily presents in three forms:
- Leukemia: Rapid, abnormal production of white blood cells in the bone marrow.
- Lymphoma: Cancers that target the lymphatic system and cause swollen lymph nodes.
- Multiple Myeloma: Cancers targeting plasma cells, disrupting healthy antibody generation.
- Global Impact: A new patient is diagnosed with blood cancer somewhere in the world every 27 to 35 seconds.
The Critical Role of Stem Cell & Bone Marrow Donation
- The Survival Path: For a vast majority of aggressive blood cancer patients, a blood stem cell or bone marrow transplant provides their only definitive chance of survival.
- The Genetic Hurdle: Finding a matching donor requires an exact match of Human Leukocyte Antigens (HLA). Only 30% of patients find a match inside their family, leaving 70% completely reliant on anonymous international registries.
- The Representation Gap: India ranks 3rd highest globally in reported blood cancer cases, yet suffers from a severe shortage of registered bone marrow donors, which drastically lowers the odds of finding matching HLA profiles for patients of South Asian descent.
Modern Symptoms and Diagnostic Markers
- Early Indicators: Early stages often mimic common, less severe illnesses, making them difficult to detect. Key signs include persistent fatigue, recurring fevers, unexplained weight loss, night sweats, bone pain, and painless swelling in the neck or underarms.
- System Failure: Advanced stages cause severe hemolytic anemia (rapid destruction of oxygen-carrying red blood cells) and frequent, dangerous bleeding or bruising due to low blood platelets.
- Diagnostic Tools: Verified using comprehensive blood panel counts, manual peripheral blood smears, or highly detailed bone marrow aspiration and biopsy tracking.
Download Pdf
